HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 22 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | -81.8% | 12,049 | -62.3% | 0.00% | -50.0% |
| Q4 2019 | $22,000 | -4.3% | 31,991 | -8.7% | 0.00% | 0.0% |
| Q3 2019 | $23,000 | -55.8% | 35,037 | +12.6% | 0.00% | -33.3% |
| Q2 2019 | $52,000 | -36.6% | 31,122 | -3.3% | 0.00% | -25.0% |
| Q4 2018 | $82,000 | -61.9% | 32,191 | -24.5% | 0.00% | -69.2% |
| Q3 2018 | $215,000 | -24.3% | 42,664 | -45.6% | 0.01% | -13.3% |
| Q1 2018 | $284,000 | +165.4% | 78,360 | +24.0% | 0.02% | +200.0% |
| Q3 2017 | $107,000 | – | 63,172 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,280,185 | $9,755,000 | 1.01% |
| Cormorant Asset Management, LP | 201,000 | $1,532,000 | 0.24% |
| PUTNAM INVESTMENTS LLC | 575,692 | $4,386,000 | 0.01% |
| Alyeska Investment Group, L.P. | 114,113 | $870,000 | 0.01% |
| VANGUARD GROUP INC | 4,355,424 | $131,473,000 | 0.01% |
| BLACKROCK ADVISORS LLC | 463,200 | $3,530,000 | 0.00% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 26,100 | $199,000,000 | 0.00% |
| Ironwood Financial, llc | 870 | $7,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 24,293 | $185,000 | 0.00% |
| Sonora Investment Management, LLC | 500 | $3,000 | 0.00% |